Annual D&A
$2.25 M
-$454.00 K-16.78%
31 December 2023
Summary:
Syros Pharmaceuticals annual depreciation & amortization is currently $2.25 million, with the most recent change of -$454.00 thousand (-16.78%) on 31 December 2023. During the last 3 years, it has fallen by -$766.00 thousand (-25.38%). SYRS annual D&A is now -25.80% below its all-time high of $3.04 million, reached on 31 December 2020.SYRS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$325.00 K
-$6000.00-1.81%
30 September 2024
Summary:
Syros Pharmaceuticals quarterly depreciation & amortization is currently $325.00 thousand, with the most recent change of -$6000.00 (-1.81%) on 30 September 2024. Over the past year, it has dropped by -$27.00 thousand (-7.67%). SYRS quarterly D&A is now -63.81% below its all-time high of $898.00 thousand, reached on 31 December 2019.SYRS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$1.34 M
-$287.00 K-17.62%
30 September 2024
Summary:
Syros Pharmaceuticals TTM depreciation & amortization is currently $1.34 million, with the most recent change of -$287.00 thousand (-17.62%) on 30 September 2024. Over the past year, it has dropped by -$910.00 thousand (-40.41%). SYRS TTM D&A is now -57.60% below its all-time high of $3.17 million, reached on 30 September 2020.SYRS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRS Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -7.7% | -40.4% |
| 3 y3 years | -25.4% | -58.0% | -55.5% |
| 5 y5 years | -17.3% | -63.8% | -50.7% |
SYRS Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -25.8% | at low | -58.0% | at low | -55.5% | at low |
| 5 y | 5 years | -25.8% | +40.4% | -63.8% | at low | -57.6% | at low |
| alltime | all time | -25.8% | +772.9% | -63.8% | +339.2% | -57.6% | +1713.5% |
Syros Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $325.00 K(-1.8%) | $1.34 M(-17.6%) |
| June 2024 | - | $331.00 K(-0.9%) | $1.63 M(-16.4%) |
| Mar 2024 | - | $334.00 K(-5.1%) | $1.95 M(-13.5%) |
| Dec 2023 | $2.25 M(-16.8%) | $352.00 K(-42.5%) | $2.25 M(-13.6%) |
| Sept 2023 | - | $612.00 K(-5.8%) | $2.60 M(-1.8%) |
| June 2023 | - | $650.00 K(+1.9%) | $2.65 M(-0.4%) |
| Mar 2023 | - | $638.00 K(-9.5%) | $2.66 M(-1.6%) |
| Dec 2022 | $2.71 M(-10.3%) | $705.00 K(+7.0%) | $2.71 M(-2.5%) |
| Sept 2022 | - | $659.00 K(-0.3%) | $2.77 M(-3.7%) |
| June 2022 | - | $661.00 K(-2.9%) | $2.88 M(-3.0%) |
| Mar 2022 | - | $681.00 K(-11.9%) | $2.97 M(-1.7%) |
| Dec 2021 | $3.02 M(-0.6%) | $773.00 K(+1.0%) | $3.02 M(+0.2%) |
| Sept 2021 | - | $765.00 K(+2.1%) | $3.01 M(-0.1%) |
| June 2021 | - | $749.00 K(+2.5%) | $3.02 M(-0.3%) |
| Mar 2021 | - | $731.00 K(-4.8%) | $3.02 M(-0.4%) |
| Dec 2020 | $3.04 M(+11.5%) | $768.00 K(+0.1%) | $3.04 M(-4.1%) |
| Sept 2020 | - | $767.00 K(+1.3%) | $3.17 M(+4.1%) |
| June 2020 | - | $757.00 K(+1.9%) | $3.04 M(+3.7%) |
| Mar 2020 | - | $743.00 K(-17.3%) | $2.93 M(+7.8%) |
| Dec 2019 | $2.72 M | $898.00 K(+39.7%) | $2.72 M(+20.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $643.00 K(-0.9%) | $2.26 M(+11.6%) |
| June 2019 | - | $649.00 K(+22.0%) | $2.02 M(+15.6%) |
| Mar 2019 | - | $532.00 K(+23.1%) | $1.75 M(+9.0%) |
| Dec 2018 | $1.60 M(+5.0%) | $432.00 K(+5.9%) | $1.60 M(+2.7%) |
| Sept 2018 | - | $408.00 K(+8.5%) | $1.56 M(+1.1%) |
| June 2018 | - | $376.00 K(-3.1%) | $1.54 M(-0.3%) |
| Mar 2018 | - | $388.00 K(-0.5%) | $1.55 M(+1.5%) |
| Dec 2017 | $1.53 M(+20.0%) | $390.00 K(-0.3%) | $1.53 M(+3.5%) |
| Sept 2017 | - | $391.00 K(+2.6%) | $1.48 M(+5.4%) |
| June 2017 | - | $381.00 K(+4.4%) | $1.40 M(+4.9%) |
| Mar 2017 | - | $365.00 K(+8.0%) | $1.33 M(+4.8%) |
| Dec 2016 | $1.27 M(+111.5%) | $338.00 K(+7.3%) | $1.27 M(+9.4%) |
| Sept 2016 | - | $315.00 K(-0.3%) | $1.16 M(+12.1%) |
| June 2016 | - | $316.00 K(+3.9%) | $1.04 M(+24.8%) |
| Mar 2016 | - | $304.00 K(+32.8%) | $832.00 K(+38.2%) |
| Dec 2015 | $602.00 K(+133.3%) | $229.00 K(+21.2%) | $602.00 K(+61.4%) |
| Sept 2015 | - | $189.00 K(+71.8%) | $373.00 K(+102.7%) |
| June 2015 | - | $110.00 K(+48.6%) | $184.00 K(+148.6%) |
| Mar 2015 | - | $74.00 K | $74.00 K |
| Dec 2014 | $258.00 K | - | - |
FAQ
- What is Syros Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals quarterly D&A year-on-year change?
- What is Syros Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals TTM D&A year-on-year change?
What is Syros Pharmaceuticals annual depreciation & amortization?
The current annual D&A of SYRS is $2.25 M
What is the all time high annual D&A for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high annual depreciation & amortization is $3.04 M
What is Syros Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of SYRS is $325.00 K
What is the all time high quarterly D&A for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high quarterly depreciation & amortization is $898.00 K
What is Syros Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, SYRS quarterly depreciation & amortization has changed by -$27.00 K (-7.67%)
What is Syros Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of SYRS is $1.34 M
What is the all time high TTM D&A for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high TTM depreciation & amortization is $3.17 M
What is Syros Pharmaceuticals TTM D&A year-on-year change?
Over the past year, SYRS TTM depreciation & amortization has changed by -$910.00 K (-40.41%)